Alexandra Cellucci was 28 when she was diagnosed with neurofibromatosis, a rare genetic disease that causes noncancerous tumors to growon thebody's nervous tissues. She was also eight months pregnant at the time, but she would eventually delivera healthy baby girl.
Neurofibromatosis,known as NF for short,runs in Cellucci'sfamily, so sheknew her daughter could have the diseaseand she could pass it on to futurechildren. So sheand her husband, Marc, used reproductive medicine to conceive another baby, hadthe embryostested for the gene that causes NFand had doctors implantembryos in her womb without the mutatedgene.
Alex Cellucci, 35, rubs fabric on her right eye, where she had a tumor removed the previous day, while watching a movie with her daughter, Maible, 6, at their home in Quincy, Mass. on Tuesday, Aug. 6, 2019. Alex and Maible both have neurofibromatosis, a genetic disorder that causes tumors to form on nerve tissue. Alex was diagnosed with neurofibromatosis type 2 at age 28 and has since endured two MRI scans every year to monitor tumors.(Photo: Nic Antaya, Special to The Detroit News)
Cellucci, now 35, never got pregnant again, despite many attempts. She and her husband have since learned their daughter Maible, now6,also carriesthe gene for NF2, one of the three forms of the disease. The day before Maible's birthday last November,the girl asked if she had the disease. Cellucci said she told her yes and that she would be OK.
That's why the Massachusetts coupledonated seven embryos with the NF2 gene to the University of Michigan soresearchers could create an embryonic stem cell line that other researchers could study, with the hope of one day discovering a breakthrough. In a perfect world, such a development would come before their daughter endures any symptoms.
Alex Cellucci, 35, poses for a portrait at her home in Quincy, Mass. on Tuesday, Aug. 6, 2019. Alex and her 6-year-old daughter, Maible, both have neurofibromatosis, a genetic disorder that causes tumors to form on nerve tissue.(Photo: Nic Antaya, Special to The Detroit News)
I just wanted hope," said Cellucci, who had surgery last monthto remove a benigntumorbehind her eye. "They could possibly find a cure for (Maible) ... and offer hope for other families."
UM researchers have turned the Celluccis' embryos intothe firststem cell line that models NF2, which is one of the more rare forms of the disease. Besides the tumor growth, NF2 comes with a host of issues, including hearing loss, ringing in the ears and loss of balance. Symptoms typically appear in the teen years.
The embryonic stem cell line modeling the disease, created by ProfessorGary Smith, director ofthe MStem Cell Laboratories,has been acceptedonto the National Institutes of Health Human Embryonic Stem Cell Registryforother scientists to study and make discoveries around interventions anda possible cure. Another line also is under review.
Alex Cellucci, 35, watches a movie at her home in Quincy, Mass., a day after having a tumor removed from behind her right eye.(Photo: Nic Antaya, Special to The Detroit News)
Researchers can apply to access the stem cell lines on thefederal registryto study how diseases form and develop, with the aim of finding ways to better understand, treat, delay and possibly even cure diseases.
Smith has derived all of UM's56embryonic stem cell lines on the national registry, including 36 disease-specific lines. Hesaid the personal stories behind all of those stem cell lines are important.
"We just don't do science to do science," Smith said. "We do science to help others. Here is a family that recognizes that. Sometimes that gets lost on people. ... We really do want to help people."
The NF2 stem cell line comes as neurofibromatosis scientists andclinicians prepare to gather next month for their annual conference in San Francisco.
Alex Cellucci, 35, and her daughter, Maible, 6, watch a movie at their home in Quincy, Mass. on Tuesday, Aug. 6, 2019. Alex and Maible both have neurofibromatosis, a genetic disorder that causes tumors to form on nerve tissue. Alex was diagnosed with neurofibromatosis type 2 at age 28 and has since had two MRI scans done every year to monitor tumors. Most recently, Alex had a tumor removed behind her right eye on Aug. 5, 2019.(Photo: Nic Antaya, Special to The Detroit News)
It also comes as Detroitbusinessman andCleveland Cavaliers ownerDan Gilbert has used philanthropy to support the small research community of neurofibromatosis. His 23-year-old son, Nick, was born with neurofibromatosis type 1.
NF2 afflicts1 in 33,000 people worldwide, while NF1 is more common, occurringin 1 in 3,000 to 4,000 people, according to the National Institutes of Health. NF1 typically begins in childhood and leads to skin changes and bone deformity.Schwannomatosis, the rarest type of NF, causes intense pain.
Gilbert, who suffered a stroke in late May,has spoken about neurofibromatosis and also about howNick, a Michigan State University student, hadto undergobrain surgery in 2018 to remove tumors.
Gilbert, a billionaire, has invested $64 million over the yearsthrough the Gilbert Family Foundation, including $12 million for gene therapy initiatives to address the underlying cause of NF1 and $11 million for vision loss in NF1 patients, which Nick grapples with, according toYooRi Kim, the foundation's scientific officer.
Marc and Alex Cellucci, and their daughter, Maible, 6, and dog Pedalino, pose for a portrait outside of their home in Quincy, Mass. on Tuesday, Aug. 6, 2019. Alex and Maible both have neurofibromatosis, a genetic disorder that causes tumors to form on nerve tissue.(Photo: Nic Antaya, Special to The Detroit News)
"With deeper understanding with each of these diseases that we've obtained over time, it's becoming more and more clear that the strategies that you would use to help each of thosepatients are going to look different," Kim said.
Even so, she said there is excitement about advances in research on other forms of NF, such as the stem cell line modeling NF2.
There arefour embryonic stem cell lines on the registry that model NF1, but theline UM created is the first for the research community studying NF2,according to Smith.
"It means a lot to the couplethat somebody is using something that otherwise would have been discarded and instead trying to make it something that can be used worldwide to understand this disease better," he said.
The stem cell line hasbeen applauded by Sally Temple, scientific director of the Neural Stem Cell Institute in Rensselaer,New York, which uses stem cell technologies to develop therapies that affect the nervous system.
Alex Cellucci, 35, and her daughter, Maible, 6, pose for a portrait outside of their home in Quincy, Mass. on Tuesday, Aug. 6, 2019. Alex and Maible, both have neurofibromatosis, a genetic disorder that causes tumors to form on nerve tissue.(Photo: Nic Antaya, Special to The Detroit News)
"It's a really wonderful and generous for the parents to do," said Temple, who is also aUM adjunct professor in the ophthalmology department. "When you make these human embryonic stem cell lines, they are essentially a resource forever for the community. It's available and it will be there for (researchers)to use forever in the future. It's not a one-time donation."
She added that this is important for the NF2 community since it is such a devastating disease.
Marc Cellucci is beyond thrilled, and hopeful of the possibilities for the stem cell line that he and his wife helped create and what it could do for his daughter, wife, in-laws and so many others with NF.
It all has to start somewhere, said Cellucci,where the scientific breakthroughs happen, and the miracles begin.
- Analysis Determines Cost Effectiveness of Various Treatment Strategies for Multiple Myeloma - Cancer Therapy Advisor - October 11th, 2019
- Stem cell therapy helped Owen Franks but there's still plenty to prove - Stuff.co.nz - October 11th, 2019
- AgeX Therapeutics to Present at Metabesity 2019 - Business Wire - October 11th, 2019
- Stem Cell Characterization Kits Market 08-Year Market Forecast and Trends Analysis Research Report - The Tribune City - October 10th, 2019
- New Cambridge research could lead to novel cancer therapies - Business Weekly - October 10th, 2019
- Global 3D Bioprinting Market Outlook, 2019-2024 - Market Anticipated to Reach $1.64 Billion by 2024 - ResearchAndMarkets.com - Business Wire - October 10th, 2019
- Stem Cell Cartilage Regeneration Market 2019: Prosperous Growth, Recent Trends and Demand by Top Key Vendors like Anika Therapeutics, Biomet,... - October 10th, 2019
- Industry Champion Jim Greenwood to Retire Following 2020 Elections - BioSpace - October 10th, 2019
- Cell Culture Protein Surface Coatings Market will Going to be Worth US$ 623.4 Mn by 2020 - Online News Guru - October 10th, 2019
- NIH funding bolsters rare diseases research collaborations | National Institutes of Health - National Institutes of Health - October 4th, 2019
- Stem Cell Therapy Market worth USD 4759.27 Million By 2024 - Global Market News 24 - October 4th, 2019
- Genome editing to be tested in kidney organoids - UW Medicine Newsroom - October 2nd, 2019
- First Patient Enrolled in Novel Stem Cell Trial for Heart Failure Treatment - Newswise - October 2nd, 2019
- Vor Biopharma Hires Senior Cell and Gene Therapy Leaders as Chief Technology Officer and Vice President of Research - Business Wire - October 2nd, 2019
- Now in development: off-the-shelf stem cells - Knowable Magazine - September 28th, 2019
- Immunity Against Cancer? Engineered Killer T Cells May Be the Key. - SciTechDaily - September 28th, 2019
- 'Provocative' Results With Stem Cells in Progressive MS - Medscape - September 27th, 2019
- 'I've Been Duped': Disabled Veteran Says He Spent Thousands at Health Center With No Improvement - NBC Bay Area - September 27th, 2019
- Finding alternatives to animal testing - University of California - September 27th, 2019
- Gene therapy shows promise repairing brain tissue damaged by stroke - National Institute on Aging - September 27th, 2019
- Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations - Yahoo Finance - September 27th, 2019
- Science Talk - Celebrating Professor Sir Mel Greaves and his legacy in leukaemia research - The Institute of Cancer Research - September 27th, 2019
- New restrictions put fetal tissue research in the balance - AAMCNews - September 25th, 2019
- 'I've Been Duped': Disabled Veteran Says He Spent Thousands at Health Center With No Improvement - NBC Southern California - September 25th, 2019
- New Research Suggests a Cure for HIV Could be on the Horizon - BioSpace - September 25th, 2019
- iSpecimen Increases Global Access to Hematopoietic Stem and Immune Cells - Business Wire - September 25th, 2019
- Alternative medical treatments and compassionate use - Lexology - September 25th, 2019
- Stem Cell Market to witness huge Growth during the forecast period 2019-2025: Advanced Cell Technology Inc, Cellartis AB, STEMCELL Technologies Inc ... - September 25th, 2019
- It's not 'sorry' but 'thank you' that seems to be the hardest word - Charity Today News - September 25th, 2019
- New Insight as to How Cells Maintain Their Identity - Nature World News - September 22nd, 2019
- Abortion opponents hold memorials at fetal burial sites amid battle over how these remains should be treated - Walla Walla Union-Bulletin - September 22nd, 2019
- Global Cell Isolation/Cell Separation Market Industry Analysis and Forecast (2019-2026) - ScoopJunction - September 22nd, 2019
- Can old drugs put a leash on wandering cancer cells? - Newsroom - September 22nd, 2019
- Circulating Tumor Cells and Cancer Stem Cells Market Estimated to Expand at a Robust CAGR over 2025 - Commerce Gazette - September 22nd, 2019
- Sask. woman reflects on cancer journey before leading inaugural Multiple Myeloma March - News Talk 980 CJME - September 22nd, 2019
- Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2019-2025 - Rapid News Network - September 22nd, 2019
- Global Stem Cell Therapy Market Analysis and Forecast, 2019-2029: Focus on Treatment Type, Cell Source, Indication,11 Countries' Data, and Competitive... - September 21st, 2019
- 4 Stocks to Focus on Global Biotechnology Reagents Market - Yahoo Finance - September 21st, 2019
- Editing Muscle Stem Cells with CRISPR Treats Mouse Model of Muscular Dystrophy - DocWire News - September 21st, 2019
- Mutant Tau Stiffens Axon Cytoskeleton Near Soma - Alzforum - September 21st, 2019
- Testing chemicals for birth defects using stem cells, not mice - UC Riverside - September 21st, 2019
- Global Cell Harvesting Market is Booming Market to Rapidly Growing $ 387.9 Million by 2026 with Top Key Players PerkinElmer Inc, Bertin, Tomtec,... - September 21st, 2019
- Stem Cells May Be Able To Repair The Brain - Anti Aging News - September 20th, 2019
- MS News that Caught My Eye: Stem Cell Transplants, Remyelination Agent, Tecfidera Study, Plasma Exchange and Tysabri-linked PML - Multiple Sclerosis... - September 20th, 2019
- Tiny 'envelopes' show promise for sun-damaged skin repair - Futurity: Research News - September 20th, 2019
- Hope for Sickle Cell Warriors: A Cure Exists and Support from the Black Community Could Help Save More Lives - EBONY - September 20th, 2019
- Latest Report on Stem Cell Therapy Market To Flourish And Reach USD 4759.27 Million By 2024 - News Hours Today - September 20th, 2019
- Ruth Lehmann elected as director of Whitehead Institute - MIT News - September 20th, 2019
- Regulatory heft needed to curb false promises on stem cells, says health law expert - Folio - University of Alberta - September 20th, 2019
- Releases New Report on the Stem Cell Banking Market 2017-2025 - Rapid News Network - September 20th, 2019
- In Mice and Men, Prostate Drug Reportedly Treats Parkinson's Disease? - Alzforum - September 20th, 2019
- Stem Cell-Derived Cells Market to Record an Exponential CAGR by 2025 - Commerce Gazette - September 20th, 2019
- Global & US Gene Therapy Market 2019-2020: Immunodeficiency Syndromes - The Focus of Gene Therapy - PRNewswire - September 20th, 2019
- Ten-Year Bone Cancer Survivor Rides 'Coast 2 Coast' - Curetoday.com - September 20th, 2019
- Cancer Stem Cell Market Size Research Study including Growth Factors, Types and Application to 2025 - Daily News Collectors - September 20th, 2019
- Current State Of Longevity Clinical Trials - Anti Aging News - September 20th, 2019
- Crigler-Najjar Syndrome Market Insights 2019-2026: Audentes Therapeutics Inc, Genethon SA, International Stem Cell Corp - US Trade Media - September 20th, 2019
- Global Stem Cell Antibody Market Analysis, Growth, Size, Share, Demand & Forecast 2019-2026: Thermo Fisher Scientific, Inc., Merck Group, Abcam... - September 20th, 2019
- Reported stem cell treatment could give hope to Michael Schumacher - Stuff.co.nz - September 18th, 2019
- USC researchers untangle cellular reprogramming to help treat diseases - USC News - September 18th, 2019
- India- Cell Counting Market Size is Estimated to Value $10679.7 Million By 2025: Grand View Research, Inc - MENAFN.COM - September 18th, 2019
- CyTOF Inventors Receive Prestigious Science and Technology Award from the Human Proteome Organization (HUPO) - Yahoo Finance - September 18th, 2019
- Genome-editing shows potential for treating HIV in patient - BioNews - September 18th, 2019
- New technology developed to screen for Huntington's treatments - Drug Target Review - September 18th, 2019
- Device can produce synthetic human embryo-like parts - Washington Times - September 18th, 2019
- Global Advanced Wound Care Markets to 2024: Emerging Technologies such as Crab Shell Bandages, Bacteriophages, Platelets, and Stem Cell Therapies are... - September 18th, 2019
- Growth of the Global Cord Blood Stem Cell Market Driven by Improvements in Product Design - Business Broker - September 18th, 2019
- Induced Pluripotent Stem Cell Market Estimated to be Driven by Innovation and Industrialization - Wolf Mirror - September 18th, 2019
- Research: By exploiting a feature of the immune system, researchers open the door for stem cell transplants to repair the brain - Tdnews - September 18th, 2019
- Study Of Stem Cell Cartilage Regeneration Market And Also Elements For Its Future Growth 2026 - Coherent Magazine - September 18th, 2019
- Attorney General trying to intimidate witness testifying about live fetal hearts: lawyers - Lifesite - September 18th, 2019
- Global Stem Cell Therapy Market Expects an Extensive Growth in ROI of USD 4759.27 Million By 2024 - News Hours Today - September 18th, 2019
- Demand for Stem Cell-Derived Cells Market Driven by Shifting Consumer Perceptions and Growing Awareness - My Health Reporter - September 18th, 2019
- Major Players of Serum-Free Media Market By Type: protein expression media, stem cell media, hybridoma media, primary cell media, insect cell media -... - September 18th, 2019
- Cancer Stem Cell Market Insights on Upcoming Trends 2025 - Spaceflight News - September 18th, 2019
- X4 Pharmaceuticals Appoints Renato Skerlj, Ph.D. as Senior Vice President of Research and Development - Business Wire - September 18th, 2019
- Pathogenic Escherichia coli | Nature Reviews Microbiology - May 27th, 2019
- Pathways to Stem Cell Science | Pluripotent Stem Cell ... - May 14th, 2019
- What are the unique properties of stem cells - answers.com - May 2nd, 2019
- Squamous Cell Carcinoma in Dogs and Cats - Vet360 - May 2nd, 2019